VGX Announces Initiation of IND-enabling Toxicology Studies for Candidate DNA Vaccine Products
News Aug 20, 2007
VGX Pharmaceuticals has announced that it has initiated IND-enabling pre-clinical toxicology studies for three of its DNA plasmid-based product candidates.
The candidates include vaccines for human papilloma virus for the treatment of cervical cancer (VGX-3100) and avian influenza (VGX-3400), and a therapeutic based on human growth hormone releasing hormone (VGX-3200) for cancer related cachexia.
VGX is conducting the studies in combination with its patented CELLECTRA™ electroporation device and the studies will provide pre-clinical safety data for both the product candidates as well as the device in a GLP environment.
"We are pleased that our Immune Therapeutics program has entered the GLP toxicology stage and has allowed us to fully validate our dynamic vertically integrated product development program for DNA based products," stated Dr. J. Joseph Kim, President and CEO of VGX.
All three DNA plasmid-based products have previously demonstrated efficacy in various animal models. The CELLECTRA™ device delivers DNA plasmids efficiently via the application of constant-current electroporation pulses.
The device has been tested extensively in research studies in a large number of different animal models, including non-human primates, establishing a broad safety, tolerability and efficacy profile.
The current toxicology studies will be completed in early 2008 and Investigational New Drug Applications (INDs) for the three products are expected to be filed in the first half of 2008.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE